Infographic | Management of Cardiotoxicity Induced by Anthracyclines and HER2 Antagonists
Description:
Infographic | Management of Cardiotoxicity Induced by Anthracyclines and HER2 Antagonists
This infographic addresses how patients taking medication for cancer can experience cardiovascular problems induced by the drug.
Citations
- Cardinale D, Colombo A, Lamantia G, et al. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. J AmColl Cardiol 2010;55:213-20.
- Armenian SH, Lacchetti C, Barac A, et al. Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 2017;35:893-911. Doi :10.1200/JCO.2016.70.5400
- Bowles EJ, Wellman R, Feigelson HS, et al. Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst. 2012 ;104 :1293-1305. Doi :10.1093/jnci/djs317
- Keefe DL. Anthracycline-induced cardiomyopathy. Semin Oncol. 2001 ;28(4 Suppl 12)2-7.
- Curigliano G, Lenihan D, Fradley M, et al. Management of cardiac disease in cancer patients throughout oncological treatment : ESMO consensus recommendations. Ann Oncol 2020 ;31 :171-190. Doi :10.1016/j.annonc.2019.10.023
- DailyMed - HERCEPTIN-trastuzumab injection, powder, lyophilized, for solution. U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=492dbdb2-077e-4064-bff3-372d6af0a7a2. Accessed April 27, 2020.
- DailyMed - TYKERB- lapatinib tablet. U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eee37f88-ec6a-4c30-b8aa-e2c71f93088c. Accessed April 27, 2020.
- DailyMed - PERJETA- pertuzumab injection, solution, concentrate. U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17f85d17-ab71-4f5b-9fe3-0b8c822f69ff. Accessed April 27, 2020.
- DailyMed - KADCYLA- ado-trastuzumab emtansine injection, powder, lyophilized, for solution. U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e. Accessed April 27, 2020.
- DailyMed - ENHERTU- fam-trastuzumab deruxtecan-nxki injection, powder, lyophilized, for solution. U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7e67e73e-ddf4-4e4d-8b50-09d7514910b6. Accessed April 27, 2020.
All infographics should be credited to "American College of Cardiology."
Date: January 01, 2020
Clinical Topics: Cardio-Oncology, Heart Failure and Cardiomyopathies, Acute Heart Failure, Chronic Heart Failure
Keywords: Heart Failure, Cardiomyopathies, Anthracyclines, Stroke Volume, Heart Failure, Systolic, Heart Failure, Diastolic, Cardiotoxicity